<Disease><Name>CONGENITAL DISORDER OF GLYCOSYLATION CDG-Ib (MPI)</Name><Synonym>CDG1B; MPI-CDG; SLSJ SYNDROME</Synonym><OMIM><Number>602579</Number><URL>http://omim.org/entry/602579</URL></OMIM><Orphanet><Number>79319</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79319</URL></Orphanet><Protein><Number>Mannose-6-phosphate isomerase</Number><URL>http://www.uniprot.org/uniprot/P34949</URL></Protein><ExPASy><Number>5.3.1.8</Number><URL>http://enzyme.expasy.org/EC/5.3.1.8</URL></ExPASy><Gene>15q24.1</Gene><ICD>E77.8</ICD><Summary>rare ;autosomal recessive ;mutations in the MPI gene</Summary><Symptoms><symtomp><id>2130</id><symptom>bleeding tendencies, hemorrhages / bleeding tendencies, hemorrhage</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1997</id><symptom>cirrhosis or fibrosis of liver</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2133</id><symptom>Coagulopathy/Coagulation factors / Gerinnungsfaktoren [+]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2216</id><symptom>edema</symptom><category>SKIN</category></symtomp><symtomp><id>3313</id><symptom>enteropathy, protein-loosing</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3344</id><symptom>hyperinsulinism</symptom><category>ENDOCRINE SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>3195</id><symptom>hypoglycemia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1717</id><symptom>no clinical symptoms (probably) / no clinical  significance</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2034</id><symptom>thromboembolism</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1404</id><name>Coagulopathy/Coagulation factors</name><specimen /><value /><min>    </min><max>    </max><unit /><age /><method /><comment /></metabolite><metabolite><id>2138</id><name>Sodium</name><specimen>urine</specimen><value /><min>40.00</min><max>220.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>1183</id><name>Albumin</name><specimen>plasma</specimen><value /><min>25.00</min><max>34.00</max><unit>g/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>295</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>3.60</min><max>8.00</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>312</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>1.40</min><max>3.50</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>313</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>1.80</min><max>4.50</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>314</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>3.10</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1006</id><name>Cholesterol</name><specimen>serum</specimen><value>decreased</value><min>120.00</min><max>200.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1034</id><name>Coagulopathy/Coagulation factors</name><specimen>plasma</specimen><value>decreased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1885</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1413</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>100.00</min><max>209.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment>day 1-7</comment></metabolite><metabolite><id>1609</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>12.50</min><max>58.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1844</id><name>D-Glucose</name><specimen>urine</specimen><value>decreased</value><min>76.00</min><max>810.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>47</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adolescence</age><method /><comment>fasted</comment></metabolite><metabolite><id>281</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Adulthood</age><method /><comment>fasted</comment></metabolite><metabolite><id>282</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>3.30</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment>fasted</comment></metabolite><metabolite><id>280</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>1.10</min><max>3.30</max><unit>mmol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>283</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>2.20</min><max>3.30</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, 1 day</comment></metabolite><metabolite><id>46</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>2.80</min><max>5.00</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment>fasted, &gt;1 day</comment></metabolite><metabolite><id>399</id><name>D-Glucose</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>1.70</min><max>3.70</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1134</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>2.70</min><max>4.50</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>1135</id><name>D-Glucose</name><specimen>plasma</specimen><value>decreased</value><min>3.00</min><max>4.30</max><unit>mmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>490</id><name>D-Glucose</name><specimen>blood</specimen><value>decreased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>333</id><name>D-Glucose</name><specimen>blood</specimen><value>decreased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>334</id><name>D-Glucose</name><specimen>blood</specimen><value>decreased</value><min>2.60</min><max>5.50</max><unit>mmol/l</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>409</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>134.00</min><max>146.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>413</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>728</id><name>Sodium</name><specimen>sweat</specimen><value>decreased</value><min>20.00</min><max>30.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1105</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1158</id><name>Thrombocytes, Platelets</name><specimen>blood</specimen><value>increased</value><min>100.00</min><max>350.00</max><unit>x1000/&#181;l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1157</id><name>Thrombocytes, Platelets</name><specimen>blood</specimen><value>increased</value><min>150.00</min><max>400.00</max><unit>x1000/&#181;l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>723</id><name>Transferrin</name><specimen>serum</specimen><value /><min>130.00</min><max>430.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7917</id><title>Consensus guideline for the diagnosis and management of mannose phosphate isomerase-congenital disorder of glycosylation (MPI-C</title><author>Cechova A,</author><journal>J Inherit Metab Dis</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et. al.</co_aut></literature><literature><id>6440</id><title>MPI-CDG with transient hypoglycosylation and antithrombin deficiency</title><author>de la Morena-Barrio ME,</author><journal>Haematologica</journal><year>2019</year><book /><volume>104</volume><number>2</number><pages>e79-82</pages><co_aut>et al.</co_aut></literature><literature><id>3405</id><title>Asymptomatic phosphomannose isomerase deficiency (MPI-CDG) initially mistaken for excessive alcohol consumption</title><author>Helander A,</author><journal>Clin Chim Acta</journal><year>2014</year><book /><volume>431</volume><number>0</number><pages>15-18</pages><co_aut>et al.</co_aut></literature><literature><id>3406</id><title>Mannose supplements induce embryonic lethality and blindness in phosphomannose isomerase hypomorphic mice</title><author>Sharma V,</author><journal>FASEB J</journal><year>2014</year><book /><volume>28</volume><number>4</number><pages>1854-1869</pages><co_aut>et al.</co_aut></literature><literature><id>3407</id><title>The metabolic origins of mannose in glycoproteins</title><author>Ichikawa M,</author><journal>J Biol Chem</journal><year>2014</year><book /><volume>289</volume><number>10</number><pages>6751-6761</pages><co_aut>et al.</co_aut></literature><literature><id>3408</id><title>Identification of intercellular cell adhesion molecule 1 (ICAM-1) as a hypoglycosylation marker in congenital disorders of glycosylation cells.</title><author>He P,</author><journal>J Biol Chem</journal><year>2012</year><book /><volume>287</volume><number>22</number><pages>18210-1821</pages><co_aut>et al.</co_aut></literature><literature><id>3000</id><title>Comparison between high performance liquid chromatography and capillary zone electrophoresis for the diagnosis of congenital di</title><author>Quintana E</author><journal>J Chromatogr B Analyt Technol Biomed Life Sci</journal><year>2009</year><book /><volume>877</volume><number>24</number><pages>2513-2518</pages><co_aut>et al.</co_aut></literature><literature><id>2996</id><title>The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib</title><author>de Lonlay P</author><journal>Biochim Biophys Acta</journal><year>2008</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Seta N</co_aut></literature><literature><id>2997</id><title>Recurrent thrombo-embolism in a child with a congenital disorder of glycosylation (CDG) type Ib and treatment with mannose</title><author>Tamminga RY</author><journal>Pediatr Hematol Oncol</journal><year>2008</year><book /><volume>25</volume><number>8</number><pages>762-768</pages><co_aut>et al.</co_aut></literature><literature><id>2998</id><title>Development of liver disease despite mannose treatment in two patients with CDG-Ib</title><author>Mention K</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>93</volume><number>1</number><pages>40-43</pages><co_aut>et al.</co_aut></literature><literature><id>2999</id><title>Using heparin therapy to reverse protein-losing enteropathy in a patient with CDG-Ib</title><author>Liem YS</author><journal>Nat Clin Pract Gastroenterol Hepatol</journal><year>2008</year><book /><volume>5</volume><number>4</number><pages>220-224</pages><co_aut>et al.</co_aut></literature><literature><id>3001</id><title>Laboratory diagnosis of congenital disorders of glycosylation type I by analysis of transferrin glycoforms</title><author>Babovic-Vuksanovic D</author><journal>Mol Diagn Ther</journal><year>2007</year><book /><volume>11</volume><number>5</number><pages>303-311</pages><co_aut>OBrien JF</co_aut></literature><literature><id>2525</id><title>Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and I</title><author>Damen G</author><journal>J Pediatr Gastroenterol Nutr</journal><year>2004</year><book /><volume>38</volume><number>3</number><pages>282-287</pages><co_aut>et al.</co_aut></literature><literature><id>2526</id><title>Protein losing enteropathy-hepatic fibrosis syndrome in Saguenay-Lac St-Jean, Quebec is a congenital disorder of glycosylation </title><author>Vuillaumier-Barrot S</author><journal>J Med Genet</journal><year>2002</year><book /><volume>39</volume><number>11</number><pages>849-851</pages><co_aut>et al.</co_aut></literature><literature><id>1283</id><title>A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases</title><author>de Lonlay P</author><journal>J Med Genet</journal><year>2001</year><book /><volume>38</volume><number>1</number><pages>14-19</pages><co_aut>et al.</co_aut></literature><literature><id>2527</id><title>Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effe</title><author>Westphal V</author><journal> Mol Genet Metab</journal><year>2001</year><book /><volume>73</volume><number>1</number><pages>77-85</pages><co_aut>et al.</co_aut></literature><literature><id>1287</id><title>Genomic organization of the human phosphomannose isomerase (MPI) gene and mutation analysis in patients with congenital disorde</title><author>Schollen E</author><journal>Hum Mutat</journal><year>2000</year><book /><volume>16</volume><number>3</number><pages>247-252</pages><co_aut>et al.</co_aut></literature><literature><id>1118</id><title>Severe hypoglycemia as a presenting symptom of carbohydrate-deficient glycoprotein syndrome</title><author>Babovic-Vuksanovic D</author><journal>J Pediatr</journal><year>1999</year><book /><volume>135</volume><number>0</number><pages>775-781</pages><co_aut>et al.</co_aut></literature><literature><id>998</id><title>Carbohydrate-deficient glycoprotein syndrome type Ib: phosphomannose isomerase deficiency and mannose therapy</title><author>Niehues R</author><journal>J Clin Invest</journal><year>1998</year><book /><volume>101</volume><number>0</number><pages>1414-1420</pages><co_aut>et al.</co_aut></literature><literature><id>1004</id><title>A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency</title><author>de Koning TJ</author><journal>Biochem Biophys Res Commun</journal><year>1998</year><book /><volume>245</volume><number>0</number><pages>38-42</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>